betadine vag.gel 10%
lavipharm ae ΑΓ.ΜΑΡΙΝΑΣ, 19002 ΠΑΙΑΝΙΑ 6691600 - povidone-iodine - vag.gel (ΚΟΛΠΙΚΗ ΓΕΛΗ) - 10% - povidone-iodine 100mg - povidone-iodine
betadine vag.sol 10%
lavipharm ae ΑΓ.ΜΑΡΙΝΑΣ, 19002 ΠΑΙΑΝΙΑ 6691600 - povidone-iodine - vag.sol (ΚΟΛΠΙΚΟ ΔΙΑΛΥΜΑ) - 10% - povidone-iodine 100mg - povidone-iodine
betadine med.l.soap 7.5%
lavipharm ae ΑΓ.ΜΑΡΙΝΑΣ, 19002 ΠΑΙΑΝΙΑ 6691600 - povidone-iodine - med.l.soap (ΣΑΠΟΥΝΙ ΥΓΡΟ ΦΑΡΜΑΚΕΥΤΙΚΟ) - 7.5% - povidone-iodine 75mg - povidone-iodine
betadine tinct 10%
lavipharm ae ΑΓ.ΜΑΡΙΝΑΣ, 19002 ΠΑΙΑΝΙΑ 6691600 - povidone-iodine - tinct (ΒΑΜΜΑ) - 10% - povidone-iodine 100mg - povidone-iodine
betadine med.shamp 4%
lavipharm ae ΑΓ.ΜΑΡΙΝΑΣ, 19002 ΠΑΙΑΝΙΑ 6691600 - povidone-iodine - med.shamp (ΣΑΠΩΝ ΓΙΑ ΤΟ ΤΡΙΧΩΤΟ ΤΗΣ ΚΕΦΑΛΗΣ (ΣΑΜΠΟΥΑΝ)) - 4% - povidone-iodine 40mg - povidone-iodine
betadine vag.sup 200mg/sup
lavipharm ae ΑΓ.ΜΑΡΙΝΑΣ, 19002 ΠΑΙΑΝΙΑ 6691600 - povidone-iodine - vag.sup (ΚΟΛΠΙΚΟ ΥΠΟΘΕΤΟ) - 200mg/sup - povidone-iodine 200mg - povidone-iodine
betadine cream 5%
lavipharm ae ΑΓ.ΜΑΡΙΝΑΣ, 19002 ΠΑΙΑΝΙΑ 6691600 - povidone-iodine - cream (ΚΡΕΜΑ) - 5% - povidone-iodine 50mg - povidone-iodine
ranitidine/kleva 50mg/2ml amp ενεσιμο διαλυμα
ΚΛΕΒΑ ΑΦΒΕΕ (0000006493) Λεωφ. Πάρνηθος 189,, Αχαρνές Αττικής, 136 75 - ranitidine hydrochloride - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 50mg/2ml amp - 0066357593 ranitidine hydrochloride 27.900000 mg - ranitidine
betadine sol.ga.m.w 1%
lavipharm ae ΑΓ.ΜΑΡΙΝΑΣ, 19002 ΠΑΙΑΝΙΑ 6691600 - povidone-iodine - sol.ga.m.w (ΔΙΑΛΥΜΑ ΓΙΑ ΓΑΡΓΑΡΕΣ Η ΓΙΑ ΕΚΠΛΥΣΕΙΣ ΣΤΟΜΑΤΟΣ) - 1% - povidone-iodine 10mg - various
azacitidine celgene
celgene europe bv - αζακιτιδίνη - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - Αντινεοπλασματικοί παράγοντες - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.